Syndax Pharmaceuticals, Inc. (SNDX) Ownership

NASDAQ Currency in USD Disclaimer

$13.07

south_east -$0.24 (-1.8%)
Day's range
$12.91
Day's range
$13.32

Syndax Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 11/13/2024 8.24 M $158.60 M   100.00% 9.64%
KYNAM CAPITAL MANAGEMENT, LP 11/14/2024 5.84 M $112.48 M   2.11% 6.84%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 4.99 M $95.98 M   -32.06% 5.84%
VANGUARD GROUP INC 11/13/2024 4.89 M $94.07 M   1.87% 5.72%
EVERSEPT PARTNERS, LP 11/14/2024 4.11 M $79.03 M   13.61% 4.81%
AVORO CAPITAL ADVISORS LLC 11/14/2024 3.89 M $74.85 M   0.00% 4.55%
STATE STREET CORP 11/14/2024 3.77 M $72.59 M   4.10% 4.41%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 2.78 M $53.48 M   -0.16% 3.25%
AVIDITY PARTNERS MANAGEMENT LP 11/14/2024 2.46 M $47.26 M   -26.39% 2.87%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.98 M $38.07 M   3.48% 2.31%
ORBIMED ADVISORS LLC 11/14/2024 1.93 M $37.06 M   0.00% 2.25%
WOODLINE PARTNERS LP 11/14/2024 1.90 M $36.50 M   22.68% 2.22%
FRANKLIN RESOURCES INC 11/27/2024 1.76 M $34.95 M   13.38% 2.06%
STEMPOINT CAPITAL LP 11/13/2024 1.73 M $33.33 M   22.59% 2.03%
GOLDMAN SACHS GROUP INC 11/14/2024 1.61 M $31.03 M   11.64% 1.89%
FIRST TURN MANAGEMENT, LLC 11/07/2024 1.19 M $22.85 M   85.38% 1.39%
MILLENNIUM MANAGEMENT LLC 11/14/2024 1.12 M $21.56 M   5.11% 1.31%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2024 1.09 M $21.00 M   32.00% 1.28%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2024 1.03 M $19.92 M   25.89% 1.21%
AISLING CAPITAL MANAGEMENT LP 11/13/2024 1.03 M $19.73 M   0.00% 1.20%
KINGDON CAPITAL MANAGEMENT, L.L.C. 11/14/2024 1.00 M $19.25 M   11.73% 1.17%
CANDRIAM S.C.A. 11/13/2024 998,619 $19.22 M   2.94% 1.17%
MARSHALL WACE, LLP 11/14/2024 989,904 $19.06 M   -45.92% 1.16%
MORGAN STANLEY 11/14/2024 887,145 $17.08 M   17.31% 1.04%
TWO SIGMA INVESTMENTS, LP 11/14/2024 886,494 $17.07 M   -4.78% 1.04%
COMMODORE CAPITAL LP 11/14/2024 885,000 $17.04 M   7.27% 1.04%
FORESITE CAPITAL MANAGEMENT IV, LLC 11/14/2024 875,000 $16.84 M   0.00% 1.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2024 817,600 $15.74 M   -4.93% 0.96%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 11/08/2024 787,785 $15.17 M   100.00% 0.92%
SOFINNOVA INVESTMENTS, INC. 11/13/2024 786,999 $15.15 B   -63.46% 0.92%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2024 786,990 $15.15 M   100.00% 0.92%
BANK OF AMERICA CORP /DE/ 11/14/2024 757,307 $14.58 M   -11.14% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 695,947 $13.40 M   6.33% 0.81%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2024 683,202 $13.15 M   129.80% 0.80%
TWO SIGMA ADVISERS, LP 11/14/2024 669,352 $12.89 M   7.74% 0.78%
GRANAHAN INVESTMENT MANAGEMENT, LLC 11/14/2024 664,765 $12.80 M   11.84% 0.78%
JPMORGAN CHASE & CO 11/08/2024 627,679 $12.08 M   -0.35% 0.73%
PROSIGHT MANAGEMENT, LP 11/14/2024 554,103 $10.67 M   0.46% 0.65%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2024 526,702 $10.14 M   -19.84% 0.62%
PARKMAN HEALTHCARE PARTNERS LLC 11/14/2024 508,283 $9.78 M   -15.38% 0.59%
SATURN V CAPITAL MANAGEMENT LLC 11/14/2024 501,978 $9.66 M   19.62% 0.59%
POLAR CAPITAL HOLDINGS PLC 11/14/2024 500,000 $9.63 M   100.00% 0.59%
AMERIPRISE FINANCIAL INC 11/14/2024 486,228 $9.36 M   -6.69% 0.57%
CASDIN CAPITAL, LLC 11/14/2024 475,000 $9.14 M   216.67% 0.56%
ALGERT GLOBAL LLC 11/12/2024 474,998 $9.14 M   9.92% 0.56%
ASSENAGON ASSET MANAGEMENT S.A. 10/23/2024 466,028 $8.97 M   8.64% 0.55%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 459,532 $8.85 M   -17.41% 0.54%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2024 453,232 $8.72 M   0.00% 0.53%
GHOST TREE CAPITAL, LLC 11/14/2024 450,000 $8.66 M   28.57% 0.53%
CRESTLINE MANAGEMENT, LP 11/13/2024 428,538 $8.25 M   199.09% 0.50%

Syndax Pharmaceuticals, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of SNDX shares?

During the previous two years, 248 institutional investors and hedge funds held shares of Syndax Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 8.24 M

Kynam Capital Management, LP: 5.84 M

WELLINGTON MANAGEMENT GROUP LLP: 4.99 M

VANGUARD GROUP INC: 4.89 M

Eversept Partners, LP: 4.11 M

Avoro Capital Advisors LLC: 3.89 M

What percentage of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors?

104.05% of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors.

How much institutional buying is happening at SNDX ?

Institutional investors have bought a total of 96.76 M shares in the last 24 months. This purchase volume represents approximately $1.26 B in transactions.